Aortic Microsomal Prostacyclin Synthesis During Diet Induced Hypercholesterolemia

  • Stuart I. Myers
Part of the GWUMC Department of Biochemistry Annual Spring Symposia book series (GWUN)

Abstract

Atherosclerosis was induced in male rabbits with administration of a 2% cholesterol diet up to 18 weeks and assessed for aortic microsomal prostanoid synthesis, morphologic assessment and serum cholesterol levels. Serum levels of cholesterol increased from control values of 84±9 ng/dl to 1632±227 ng/dl at 2 weeks (20 fold increase), and 4859±829 ng/dl at 9 weeks (57 fold increase). Aortic microsomal prostacyclin synthesis fell significantly at 2 weeks of cholesterol feeding which, predated the morphologic appearance of atherosclerotic plaque in the 7 week group. Aortic microsomal PGI2 synthesis significantly increased by 7 weeks and did not fall until the 18 week group when a highly significant increase in aortic plaque developed. These findings suggest a triphasic response of aortic PGI2 synthesis with the development of early atherosclerosis. Phase one is a fall in aortic PGI2 synthesis which predates the appearance of plaque. In phase 2, a significant rise in aortic PGI2 with the appearance of plaque could represent compensation of aortic endothelium to prevent further plaque development. In phase 3, decreased aortic PGI2 could indicate replacement of normal endothelium by atherosclerotic plaque. Aortic microsomes prepared from the female rabbits fed a cholesterol enriched diet up to 12 weeks demonstrated results similar to the male groups.

Keywords

Atherosclerotic Plaque Cholesterol Diet High Cholesterol Diet Early Atherosclerosis Rabbit Aorta 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Sinzinger, H., Clopath, P., Siberhover, K., and Winter, M., 1980, Is the variation in the susceptibility of various species to atherosclerosis due to inborn differences in prostacyclin (PGI2) formation?, Experientia, 36: 321–323.PubMedCrossRefGoogle Scholar
  2. 2.
    Dembinska-Kiec, A., Gryglewska, T., Zmuda, A., Gryglewski, R.J., 1977, The generation of prostacyclin by arteries and by the coronary vascular bed is reduced in experimental atherosclerosis in rabbits, Prostaglandins, 14: 1025–1034.PubMedCrossRefGoogle Scholar
  3. 3.
    Zmuda, A., Dembinska-Riec, A., Chytkowski, A., Gryglewski, R.J., 1977, Experimental atherosclerosis in rabbits: Platelet aggregation and antiaggregatory potency of prostacyclin, Prostaglandins, 14: 1035–1042.Google Scholar
  4. 4.
    Gryglewski, R.J., Dembinska-Kiec, A., Zmuda, A., Gryglewska, T., 1978, Prostacyclin and thromboxane A2 biosynthesis capacities of heart, arteries, and platelets at various stages of experimental atherosclerosis in rabbits, Atherosclerosis, 31: 385–394.PubMedCrossRefGoogle Scholar
  5. 5.
    Voss, R., 1983, Prostacyclin-formulation by the rabbit aorta: relation to atherosclerosis, Prostaglandins, Leukotrienes and Medicine, 11: 451–456.Google Scholar
  6. 6.
    Henriksson, P., Stamberger, M., and Diczfalusy, U., 1987, Increased aortic thromboxane production in experimental atherosclerosis. Prost Leuk and Medicine, 29: 71–77.CrossRefGoogle Scholar
  7. 7.
    Beetens, J.R., Coene, M.C., Verheyen, A., Zonnekeyn, L., Herman, A.G., 1986, Biphasic response of intimal prostacyclin production during the development of experimental atherosclerosis, Prostaglandins, 32: 319–323.PubMedCrossRefGoogle Scholar
  8. 8.
    Simon, T.C., Makheja, A.N., and Bailey, J.M., 1989, Formation of 15-hydroxyeicosatetraenoic acid (15-BETE) as the predominant eicosanoid in aortas from Watnube Heritable Hyperlipidemic and cholestrol fed rabbits, Atherosclerosis, 75: 13–38.CrossRefGoogle Scholar
  9. 9.
    Willis, A.C, Smith, L., and Vigo, C., 1986, Suppression of principal atherosclerosis mechanisms by prostacyclins and other eicosanoids, Drug Lipid Res., 25: 645–666.Google Scholar
  10. 10.
    Hamberg, M.J., Samuelsson, B., Svensson, J., 1975, Thromboxane: a new group of biologically active compounds derived from prostaglandin endoperoxides, Proc. Nat. Acad. Sci. USA, 74: 2994–2998.Google Scholar
  11. 11.
    Samuelsson, B., Bamberg, M., Malmsten, C., Svensson, J., 1976, The role of prostaglandin endoperoxides and thromboxanes in platelet aggregation, In: Advances In Prostaglandin And Thromboxane Research. ( B. Samuelsson and R. Paoletti, eds.) Raven Press, New York, NY, p. 737.Google Scholar
  12. 12.
    Needleman, P., Moncada, S., Bunting, S., Vane, J.R., Bamberg, M., Samuelsson. B., 1976, Identification of an enzyme in platelet microsomes which generates thromboxane A2 from prostaglandin-endoperoxides, Nature, London, 261: 558–560.Google Scholar
  13. 13.
    Ellis, E.F., Oelz, O., Roberts, L.J., Payne, A.L., Sweetman, B.J., Nies, A.S., and Oats, J., Coronary arterial smooth muscle contribution by a substance released from platelets: evidence that it is thromboxane A2, Science, 193: 1135, 1976.PubMedCrossRefGoogle Scholar
  14. 14.
    Moncada, S., Gryglewski, R., Bunting, S., and Vane, J.R., 1976, An enzyme isolated from arteries transforms prostaglandin endoperoxides into an unstable substance that inhibits platelet aggregation, Nature London, 263: 663–665.PubMedCrossRefGoogle Scholar
  15. 15.
    Gryglewski, R., Bunting, S., Moncada, S., Flower, R.J., Vane, J.R., 1976, Arterial walls are protected against deposition of platelet thrombi by a substance (prostaglandin X) which they make from prostaglandin endoperoxides, Prost. 2: 685–714.Google Scholar
  16. 16.
    Moncada, S., Higgs, E.A., and Vane, J.R., 1977, Human arterial and venous tissues generate prostacyclin (prostaglandin X) a potent inhibitor of platelet aggregation, Lancet, I: 18–20.Google Scholar
  17. 17.
    Myers, S.I., Russell, D.H., Parks, L., and Reed, M.R., 1991, Triphasic response of prostacyclin production in rabbit thoracic aorta in early atherosclerosis, (in press, Prost., Leuk., and Essential Fatty Acids).Google Scholar
  18. 18.
    Ellefson, R.D., Caraway, W.T., 1976, In: Fundamentals of Clinical Chemistry, (N.M. Tietz, ed.) Saunders, Phila., Penna., p. 506.Google Scholar
  19. 19.
    Salmon, J.R., Smith, D.R., Flower, R.J., Moncada, S., and Vane, J.R., 1978, Further studies on the enzymatic conversion of prostaglandin endoperoxides into prostacyclin by porcine aorta microsomes, Biochimica et Biophysica Acta, 523: 250–262.PubMedCrossRefGoogle Scholar
  20. 20.
    Myers, S.I., Zipser, R.A., and Needleman, P., 1981, Peptide induced prostaglandin biosynthesis in the renal vein constricted kidney, Biochem. J., 198: 357–363.Google Scholar
  21. 21.
    Myers, S.I., 1985, Effect of estrogen on rabbit gallbladder prostaglandin biosynthesis, J. of Surg Res 38: 630–634.CrossRefGoogle Scholar
  22. 22.
    McCluskey, F.R., Corr, P.B., Lee, B.I., Soffitz, J.E., Needleman, P., 1982, The arachidonic acid metabolic capacity of canine myocardium is increased during healing of acute myocardial infarction, Circ. Res., 51: 743–750.Google Scholar
  23. 23.
    LeDuc, L.E., and Needleman, P., 1976, Regional localization of prostacyclin and thromboxane synthesis in dog stomach and intestinal tract, J. Pharmacol. Exp. Therapeutics, 211: 181–188.Google Scholar
  24. 24.
    Lysz, T.W., and Needleman, P., 1982, Evidence for two distinct forms of fatty acid cyclooxygenase in the brain, J. Neurochem, 38: 1111–1117.PubMedCrossRefGoogle Scholar
  25. 25.
    Myers, S.I., Bartula, L., Linzel, M., Phan, T., Jung, P., and Merrell, R.C., 1990, The effect of diabetes mellitus on aortic prostanoid synthesis and serum cholesterol levels in the rat fed a high cholesterol diet, Life sciences, 47: 587–594.PubMedCrossRefGoogle Scholar
  26. 26.
    Smith, W.L., and Lands W.E.M., 1972, Oxygenation of polyunsaturated fatty acids during prostaglandin biosynthesis by sheep vesicular glands, Biochemistry, 11: 3276–3285.PubMedCrossRefGoogle Scholar
  27. 27.
    Bradford, M., 1976, A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding, Anal Biochem, 72: 248–254.PubMedCrossRefGoogle Scholar
  28. 28.
    Eckenfels, A., and Vane, J.R., 1972, Prostaglandins, oxygen tension and smooth muscle tone, Brit. J. Pharm., 45: 451–462.Google Scholar
  29. 29.
    Needleman, P., Raz, A., Ferrendelli, J.A., and Minkes, M., 1977, Application of imidazole as a selective inhibitor of thromboxane synthetase in human platelets, Proc. Nat. Acad. Sci. USA, 74: 1716–1720.Google Scholar
  30. 30.
    Harnberg, M., and Samuelsson, B., 1966, Prostaglandins in human seminal plasma. J. Biol. Chem, 241: 257–263.Google Scholar
  31. 31.
    Nugteren, D.H., and Hazelhof, E., 1973, Isolation and properties of intermediates in prostaglandin biosynthesis, Biochem. Biophys. Acta, 326: 448–461.Google Scholar
  32. 32.
    Myers, S.I., Haley-Russell, D., Bartula, L., and Nabzdyk, w., 1991, Long-term cholesterol feeding stimulates increased bile phospholipids and gallbladder prostanoid synthesis, surgery, 109 (5): 656–662.Google Scholar

Copyright information

© Springer Science+Business Media New York 1991

Authors and Affiliations

  • Stuart I. Myers
    • 1
  1. 1.Departments of SurgeryThe University of Texas Southwestern Medical CenterDallasUSA

Personalised recommendations